You are here » Home » Companies » Company Overview » Suven Pharmaceuticals Ltd

Suven Pharmaceuticals Ltd.

BSE: 543064 Sector: Health care
NSE: SUVENPHAR ISIN Code: INE03QK01018
BSE 10:48 | 25 Oct 519.80 -4.70
(-0.90%)
OPEN

523.50

HIGH

523.50

LOW

515.45

NSE 10:39 | 25 Oct 519.60 -5.60
(-1.07%)
OPEN

529.75

HIGH

529.75

LOW

515.50

OPEN 523.50
PREVIOUS CLOSE 524.50
VOLUME 1690
52-Week high 589.80
52-Week low 292.00
P/E 42.85
Mkt Cap.(Rs cr) 13,234
Buy Price 519.80
Buy Qty 3.00
Sell Price 520.15
Sell Qty 1.00
OPEN 523.50
CLOSE 524.50
VOLUME 1690
52-Week high 589.80
52-Week low 292.00
P/E 42.85
Mkt Cap.(Rs cr) 13,234
Buy Price 519.80
Buy Qty 3.00
Sell Price 520.15
Sell Qty 1.00
Filter:

Suven Pharmaceuticals Ltd. (SUVENPHAR) - Yearly Result

Particulars ( cr) Mar '21 Mar '20 Mar '19
Net Sales/Income From Operations 1009.72 833.79 377.83
Other Income 14.24 18.12 0.60
Total Income 1023.96 851.91 378.43
Total Expenditure 569.20 452.15 206.28
Operating Profit 454.76 399.76 172.15
Interest 9.14 18.66 2.79
Gross Profit 445.62 381.10 169.36
Depreciation 31.64 23.51 11.50
PBT 413.99 357.59 157.86
Tax 101.72 88.81 33.17
Net Profit/(Loss) 308.65 270.08 109.27
Minority Interest After NP - - -
Net Profit after Minority Interest - - -
Exceptional Items 0.00 0.00 0.00
Profit After Exceptional Items 308.65 270.08 109.27
Equity Share Capital 25.46 12.73 12.73
Reserves Excluding Revaluation Reserves 1039.73 770.10 577.56
EPS
Basic EPS 12.12 21.21 8.59
Public Share Holding
No Of Shares (Crores) 0 0 0
Share Holding (%) 0.00 0.00 0.00
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of Shares (Crores) 0 0 0
- Per. of Shares (as a % of the total sh. of prom. and promoter group) 0.00 0.00 0.00
- Per. of Shares (as a % of the total Share Cap. of the company) 0.00 0.00 0.00
b) Non-encumbered
- Number of Shares (Crores) 0 0 0
- Per. of shares (as a % of the total sh. of prom. and promoter group) 0.00 0.00 0.00
- Per. of shares (as a % of the total Share Cap. of the company) 0.00 0.00 0.00
Note : PBT include deferred tax and fringe benefit tax Net profit figures include extra-ordinary items income/expenditure.
.